147 related articles for article (PubMed ID: 38596350)
1. Real-World Experiences of Parkinson's Disease OFF Time and Role of Demographics.
Devraj R; Elkouzi A; Tracey MR
J Patient Cent Res Rev; 2024; 11(1):8-17. PubMed ID: 38596350
[TBL] [Abstract][Full Text] [Related]
2. Real-world assessment of "OFF" episode-related healthcare resource utilization among patients with Parkinson's disease in the United States.
Thach A; Jones E; Pappert E; Pike J; Wright J; Gillespie A
J Med Econ; 2021; 24(1):540-549. PubMed ID: 33819121
[TBL] [Abstract][Full Text] [Related]
3. Real-world assessment of the impact of "OFF" episodes on health-related quality of life among patients with Parkinson's disease in the United States.
Thach A; Jones E; Pappert E; Pike J; Wright J; Gillespie A
BMC Neurol; 2021 Jan; 21(1):46. PubMed ID: 33516182
[TBL] [Abstract][Full Text] [Related]
4. OFF episode quality of life impact scale (OFFELIA): A new measure of quality of life for off episodes in Parkinson's disease.
Kuharic M; Kulbokas V; Hanson K; Nazari JL; Shah KK; Nguyen A; Hensle T; Marras C; Armstrong MJ; Jalundhwala YJ; Pickard AS
Parkinsonism Relat Disord; 2024 Jun; 123():106070. PubMed ID: 38503261
[TBL] [Abstract][Full Text] [Related]
5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of Dyskinesia and OFF by 30-Minute Intervals Through the Day and Assessment of Daily Episodes of Dyskinesia and OFF: Novel Analyses of Diary Data from Gocovri Pivotal Trials.
Hauser RA; Kremens DE; Elmer LW; Kreitzman DL; Walsh RR; Johnson R; Howard R; Nguyen JT; Patni R
J Parkinsons Dis; 2019; 9(3):591-600. PubMed ID: 31081793
[TBL] [Abstract][Full Text] [Related]
7. Caregiver burden in Parkinson's disease: a mixed-methods study.
Geerlings AD; Kapelle WM; Sederel CJ; Tenison E; Wijngaards-Berenbroek H; Meinders MJ; Munneke M; Ben-Shlomo Y; Bloem BR; Darweesh SKL
BMC Med; 2023 Jul; 21(1):247. PubMed ID: 37424022
[TBL] [Abstract][Full Text] [Related]
8. Long-term results of carbidopa/levodopa enteral suspension across the day in advanced Parkinson's disease: Post-hoc analyses from a large 54-week trial.
Pahwa R; Aldred J; Merola A; Gupta N; Terasawa E; Garcia-Horton V; Steffen DR; Kandukuri PL; Bao Y; Ladhani O; Yan CH; Chaudhari V; Isaacson SH
Clin Park Relat Disord; 2023; 8():100181. PubMed ID: 36594071
[TBL] [Abstract][Full Text] [Related]
9. Off Time Independently Affects Quality of Life in Advanced Parkinson's Disease (APD) Patients but Not in Non-APD Patients: Results from the Self-Reported Japanese Quality-of-Life Survey of Parkinson's Disease (JAQPAD) Study.
Hayashi Y; Nakagawa R; Ishido M; Yoshinaga Y; Watanabe J; Kurihara K; Nagaki K; Ogura H; Mishima T; Fujioka S; Tsuboi Y
Parkinsons Dis; 2021; 2021():9917539. PubMed ID: 34676064
[TBL] [Abstract][Full Text] [Related]
10. Characteristics of fatigue in Parkinson's disease: A longitudinal cohort study.
Zhou X; Xiang Y; Song T; Zhao Y; Pan H; Xu Q; Chen Y; Sun Q; Wu X; Yan X; Guo J; Tang B; Lei L; Liu Z;
Front Aging Neurosci; 2023; 15():1133705. PubMed ID: 36967819
[TBL] [Abstract][Full Text] [Related]
11. The Most Bothersome Aspects of
Chahine LM; Edison B; Daeschler M; Mantri S; Kahl S; Rapoport R; Goyle A; Precht C; Kopil C; Marras C
Mov Disord Clin Pract; 2020 Apr; 7(3):284-292. PubMed ID: 32258226
[TBL] [Abstract][Full Text] [Related]
12. Reducing unemployment benefit duration to increase job finding rates: a systematic review.
Filges T; Jonassen AB; Jørgensen AK
Campbell Syst Rev; 2018; 14(1):1-194. PubMed ID: 37131392
[TBL] [Abstract][Full Text] [Related]
13. Open-label titration of apomorphine sublingual film in patients with Parkinson's disease and "OFF" episodes.
Hui JS; Fox SH; Neeson W; Bhargava P; Pappert E; Blum D; Navia B;
Parkinsonism Relat Disord; 2020 Oct; 79():110-116. PubMed ID: 32927285
[TBL] [Abstract][Full Text] [Related]
14. Patient Preferences for Treating "OFF" Episodes in Parkinson's Disease: A Discrete Choice Experiment.
Thach A; Sutphin J; Coulter J; Leach C; Pappert E; Mansfield C
Patient Prefer Adherence; 2021; 15():1187-1196. PubMed ID: 34103902
[TBL] [Abstract][Full Text] [Related]
15. Chronic pain in Parkinson's disease: Frequency, characteristics, independent factors, and relationship with health-related quality of life.
Ozturk EA; Gundogdu I; Kocer B; Comoglu S; Cakci A
J Back Musculoskelet Rehabil; 2016 Jun; ():. PubMed ID: 27284853
[TBL] [Abstract][Full Text] [Related]
16. Frequency, duration and predictors of bronchiolitis episodes of care among infants ≥32 weeks gestation in a large integrated healthcare system: a retrospective cohort study.
Flaherman VJ; Ragins AI; Li SX; Kipnis P; Masaquel A; Escobar GJ
BMC Health Serv Res; 2012 Jun; 12():144. PubMed ID: 22682080
[TBL] [Abstract][Full Text] [Related]
17. Feasibility of home dose optimization of apomorphine sublingual film in Parkinson's disease patients with OFF episodes: results from the dose-optimization phase of an open-label, randomized crossover study.
Kassubek J; Stocchi F; Martinez EB; Pahwa R; Ondo W; Zhang Y; Bowling A; Pappert E; Isaacson S; Wu S;
Ther Adv Neurol Disord; 2023; 16():17562864231209240. PubMed ID: 37954918
[TBL] [Abstract][Full Text] [Related]
18. Cost-Effectiveness of Apomorphine Sublingual Film as an "On-Demand" Treatment for "OFF" Episodes in Patients with Parkinson's Disease.
Thach A; Kirson N; Zichlin ML; Dieye I; Pappert E; Williams GR
J Health Econ Outcomes Res; 2021; 8(2):82-92. PubMed ID: 35178465
[No Abstract] [Full Text] [Related]
19. Apomorphine sublingual film for off episodes in Parkinson's disease: a randomised, double-blind, placebo-controlled phase 3 study.
Olanow CW; Factor SA; Espay AJ; Hauser RA; Shill HA; Isaacson S; Pahwa R; Leinonen M; Bhargava P; Sciarappa K; Navia B; Blum D;
Lancet Neurol; 2020 Feb; 19(2):135-144. PubMed ID: 31818699
[TBL] [Abstract][Full Text] [Related]
20. Study on the Clinical Features of Parkinson's Disease With Probable Rapid Eye Movement Sleep Behavior Disorder.
Long K; Wan C; Xiang Y; Liu J; Xu Q; Sun Q; Wang Z; Tian Y; Fang L; Yang Y; Yan X; Tang B; Guo J
Front Neurol; 2020; 11():979. PubMed ID: 33041969
[No Abstract] [Full Text] [Related]
[Next] [New Search]
